155 related articles for article (PubMed ID: 19468254)
1. p16ink4a is a surrogate marker for high-risk and malignant cervical lesions in the presence of human papillomavirus.
Lakshmi S; Rema P; Somanathan T
Pathobiology; 2009 May; 76(3):141-8. PubMed ID: 19468254
[TBL] [Abstract][Full Text] [Related]
2. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
3. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
4. Staining characteristics of p16INK4a: is there a correlation with lesion grade or high-risk human papilloma virus positivity?
Ozgul N; Cil AP; Bozdayi G; Usubutun A; Bulbul D; Rota S; Kose MF; Biri A; Haberal A
J Obstet Gynaecol Res; 2008 Oct; 34(5):865-71. PubMed ID: 18958930
[TBL] [Abstract][Full Text] [Related]
5. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
6. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
7. [Association between high risk HPV viral load, p16ink4a expression and intra-epithelial cervical lesions].
Eleutério Junior J; Giraldo PC; Cavalcante DI; Gonçalves AK; Eleutério RM
Rev Assoc Med Bras (1992); 2007; 53(6):530-4. PubMed ID: 18157369
[TBL] [Abstract][Full Text] [Related]
8. Gene amplification and immunohistochemical expression of ERBB2 and EGFR in cervical carcinogenesis. Correlation with cell-cycle markers and HPV presence.
Conesa-Zamora P; Torres-Moreno D; Isaac MA; Pérez-Guillermo M
Exp Mol Pathol; 2013 Oct; 95(2):151-5. PubMed ID: 23827764
[TBL] [Abstract][Full Text] [Related]
9. An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions.
Tsai HJ; Peng YW; Lin LY; Chou MC; Lee H; Chiou HL
Cancer Detect Prev; 2005; 29(6):537-43. PubMed ID: 16289504
[TBL] [Abstract][Full Text] [Related]
10. [Role of p16INK4a as a biomarker in liquid-based cervical cytology screening].
Xu T; Lu HJ; He YF
Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):211-4. PubMed ID: 18756939
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus DNA, HPV L1 capsid protein and p16
Hu H; Zhao J; Yu W; Zhao J; Wang Z; Jin L; Yu Y; Han L; Wang L; Zhu H; Li F
Arch Gynecol Obstet; 2019 Jan; 299(1):141-149. PubMed ID: 30390110
[TBL] [Abstract][Full Text] [Related]
12. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
13. The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer.
Ahmad A; Raish M; Shahid M; Batra S; Batra V; Husain SA
Cancer Biomark; 2017 Jul; 19(4):375-381. PubMed ID: 28453456
[TBL] [Abstract][Full Text] [Related]
14. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
15. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia.
Kong CS; Balzer BL; Troxell ML; Patterson BK; Longacre TA
Am J Surg Pathol; 2007 Jan; 31(1):33-43. PubMed ID: 17197917
[TBL] [Abstract][Full Text] [Related]
16. Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus.
Eleutério J; Giraldo PC; Gonçalves AK; Cavalcante DI; de Almeida Ferreira FV; Mesquita SM; Morais SS
Acta Obstet Gynecol Scand; 2007; 86(1):94-8. PubMed ID: 17230296
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?
Lorenzato M; Caudroy S; Bronner C; Evrard G; Simon M; Durlach A; Birembaut P; Clavel C
Hum Pathol; 2005 Oct; 36(10):1101-7. PubMed ID: 16226110
[TBL] [Abstract][Full Text] [Related]
18. Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas.
Liu SS; Tsang PC; Chan KY; Cheung AN; Chan KK; Leung RC; Ngan HY
Tumour Biol; 2008; 29(2):105-13. PubMed ID: 18515988
[TBL] [Abstract][Full Text] [Related]
19. Implications of continued upregulation of p16(INK4a) through the evolution from high-grade squamous intraepithelial lesion to invasive squamous carcinoma of the cervix.
Cheah PL; Looi LM; Mun KS; Abdoul Rahman N; Teoh KH
Malays J Pathol; 2011 Dec; 33(2):83-7. PubMed ID: 22299207
[TBL] [Abstract][Full Text] [Related]
20. [The p16INK4A mRNA transcripts estimation in cervical smear with different degrees of cervical dysplasia].
Janušicová V; Kapustová I; Zúbor P; Slezák P; Kajo K; Lasabová Z; Plank L; Danko J
Ceska Gynekol; 2012 Jun; 77(3):245-50. PubMed ID: 22779728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]